1. Home
  2. BEAM vs ADUS Comparison

BEAM vs ADUS Comparison

Compare BEAM & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • ADUS
  • Stock Information
  • Founded
  • BEAM 2017
  • ADUS 1979
  • Country
  • BEAM United States
  • ADUS United States
  • Employees
  • BEAM N/A
  • ADUS N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • ADUS Medical/Nursing Services
  • Sector
  • BEAM Health Care
  • ADUS Health Care
  • Exchange
  • BEAM Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • BEAM 1.9B
  • ADUS 2.0B
  • IPO Year
  • BEAM 2020
  • ADUS 2009
  • Fundamental
  • Price
  • BEAM $22.93
  • ADUS $127.02
  • Analyst Decision
  • BEAM Buy
  • ADUS Buy
  • Analyst Count
  • BEAM 10
  • ADUS 9
  • Target Price
  • BEAM $47.00
  • ADUS $132.00
  • AVG Volume (30 Days)
  • BEAM 998.5K
  • ADUS 104.3K
  • Earning Date
  • BEAM 11-05-2024
  • ADUS 11-04-2024
  • Dividend Yield
  • BEAM N/A
  • ADUS N/A
  • EPS Growth
  • BEAM N/A
  • ADUS 26.93
  • EPS
  • BEAM N/A
  • ADUS 4.20
  • Revenue
  • BEAM $352,567,000.00
  • ADUS $1,114,740,000.00
  • Revenue This Year
  • BEAM N/A
  • ADUS $11.37
  • Revenue Next Year
  • BEAM $8.94
  • ADUS $14.93
  • P/E Ratio
  • BEAM N/A
  • ADUS $30.13
  • Revenue Growth
  • BEAM 339.83
  • ADUS 11.57
  • 52 Week Low
  • BEAM $18.85
  • ADUS $81.51
  • 52 Week High
  • BEAM $49.50
  • ADUS $136.12
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 46.94
  • ADUS 39.13
  • Support Level
  • BEAM $21.79
  • ADUS $123.45
  • Resistance Level
  • BEAM $22.70
  • ADUS $129.79
  • Average True Range (ATR)
  • BEAM 1.09
  • ADUS 2.17
  • MACD
  • BEAM -0.07
  • ADUS -0.65
  • Stochastic Oscillator
  • BEAM 28.56
  • ADUS 14.63

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: